Michael W Bishop

Trials

Studies that name Michael W Bishop as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:48 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT05691478 · A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

  National Cancer Institute (NCI) · suspended · High Grade Osteosarcoma, Localized Osteosarcoma, Metastatic Osteosarcoma · principal investigator
• Ph2
  NCT03006848 · A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

  St. Jude Children's Research Hospital · completed · Osteosarcoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• COG NCTN Network Group Operations Center
  U10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026
  Named on NCT05691478